Status:
COMPLETED
Preventing Antibiotic-Associated DiarRhea Using Erceflora
Lead Sponsor:
Sanofi
Conditions:
Diarrhea, Infantile
Eligibility:
All Genders
6-12 years
Phase:
PHASE4
Brief Summary
To determine the effectiveness of the pre-biotic Bacillus clausii in preventing antibiotic associated diarrhea among hospitalized immunocompetent Filipino children.
Eligibility Criteria
Inclusion
- Clinically stable children with mild to moderate illness admitted for treatment of bacterial infection.
Exclusion
- Children with unstable medical condition
- In any form of immunocompromized state
- With contraindication to take medication
- Has taken antibiotics for 3 weeks before start of trial.
- The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
323 Patients enrolled
Trial Details
Trial ID
NCT00447161
Start Date
July 1 2006
Last Update
September 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanofi-Aventis
Manila, Philippines